3.1K Views
•
14:51 min
•
June 17th, 2022
DOI :
June 17th, 2022
•Rozdziały w tym wideo
0:00
Introduction
0:24
Selection of the Most Potent Promoter to Obtain Persistent and Prolonged Expression of the shRNAs
2:01
Preparation of Pooled Lentiviral Human Epigenetic Factor shRNA Library
4:48
Estimation of the Transduction Efficiency of Lentiviruses
6:03
Transduction of Pooled Epigenetic shRNA Library in the Drug-Resistant Cell Line
7:20
Enrichment of GFP Positive Cells
7:54
Dropout Screening to Identify Epigenetic Factors Mediating Drug Resistance
9:20
Amplification of the Integrated shRNAs by PCR
11:08
Next-Generation Sequencing and Data Analysis
11:57
Representative Results
14:30
Conclusion
Powiązane Filmy
Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
13.6K Views
Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
11.2K Views
Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells
8.2K Views
Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
7.1K Views
Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy
9.0K Views
Generation of High-Throughput Three-Dimensional Tumor Spheroids for Drug Screening
8.5K Views
Physiologic Patient Derived 3D Spheroids for Anti-neoplastic Drug Screening to Target Cancer Stem Cells
8.5K Views
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
4.1K Views
Drug Screening of Primary Patient Derived Tumor Xenografts in Zebrafish
7.9K Views
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
4.7K Views
Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone